



The prostate in the normal adult is a pear-shaped retroperitoneal 
organ that weighs approximately 20 g[1,2] and surrounds the 
bladder neck and urethra.[3] Histologically, it is composed 
of glands and fibromuscular stroma.[1,4] Three pathologic 
processes affect the prostate gland with significant frequency. 
These include benign prostatic hyperplasia (BPH), prostatic 
cancer, and prostatitis.[1,3,5] These pathological processes 
constitute serious morbidity and mortality in adult males 
worldwide with different incidences in various geographical 
areas.[6]
BPH is the most common urological disorder in males above 
40 years of age. Its clinical incidence is 8% in the 4th decade, 
but rises to 50% and 75% in the 5th and 8th decade of life 
respectively.[4,6,7] Old age and sustained androgen supply are 
the two major risk factors for its development.[6] BPH is not 
a precursor for prostate cancers, but may be related to those 
arising in transition zones.[1]
Worldwide, prostate cancer is the fifth most prevalent cancer and 
the second most diagnosed in men. Majority of the cases were 
seen in developed countries. The highest incidence rates were 
documented in some parts of America, Western and Northern 
Europe, as well as Australia/New Zealand (104.2/100,000). 
This has been attributed to the routine prostate biopsies that 
follow prostate‑specific antigen (PSA) testing.[8]
In Sub-Saharan Africa, studies have also shown prostate 
cancer to be the number one with regard to incidence and 
mortality especially in black men when compared to other 
racial groups.[8]
Background: This was a five-year retrospective study aimed at analyzing all prostate biopsies submitted to the Department of 
Pathology, Federal Medical Centre, Yola. It will also serve as a baseline or reference study for subsequent related research in the future. 
Materials and Methods: All cases registered as prostate diseases within the study period were extracted from the departmental records, 
comprising bench books and histology reports. The age of the patients, histological diagnosis, and specimen types or surgical procedures (core 
biopsy, transurethral resection of prostate, or prostatectomy) were retrieved as well. All the slides corresponding to the extracted registered 
prostate cases received in the department between January 2012 and December 2016 were retrieved, then reviewed microscopically and analyzed 
afterward. Results: A total of 634 prostate tissues were submitted for histology during the study period. 63.6% (403) of these specimens 
were prostatectomy, whereas the remaining were core biopsies. Almost all the cases (436) analyzed occurred in men 40 years and above and 
predominantly in the 7th and 8th decades. Nodular hyperplasia was the most prevalent prostatic disease seen over the study period accounting 
for 542 cases (85.5%). The second in frequency was prostatic adenocarcinoma constituting 14% (89) of the total cases. Two cases of high-grade 
prostate intraepithelial neoplasia and a case of chronic prostatic inflammation were also seen. Conclusion: This study has shown that prostate 
diseases are most prevalent in the 6th through 9th decades of life, with nodular hyperplasia being the most common lesion of the prostate.
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Prostate cancer is the most common cancer affecting Nigerian 
males but with varying and relatively high incidence rates 
ranging from 14% to 24.6%.[9]
MaterIals and Methods
All cases registered as prostate diseases within the study period 
were extracted from the departmental records, comprising bench 
books and histology reports. The age of the patients, histological 
diagnosis, and specimen types or surgical procedures (core biopsy, 
transurethral resection of prostate [TURP], or prostatectomy) were 
also retrieved from the departmental records. All the slides and 
tissue blocks of prostate specimens received in the Department of 
Pathology, Federal Medical Centre, Yola, between January 2012 
and December 2016, were included in the study. All histology 
slides stained with haematoxylin and eosin were retrieved 
and studied. Fresh sections were made from formalin‑fixed, 
paraffin‑embedded stored tissue blocks where slides were missing, 
broken, or faded. They were then reviewed microscopically.
The cases excluded from the study were those reported as 
inadequate for histological diagnosis and the ones in which 
neither slides nor the blocks could be found.
Statistical Program for Social Sciences (SPSS) version-20.0 
software (Armonk, NY: IBM Corp) was used for data analysis. 
The data were presented as simple frequency tables, figures, 
and photomicrographs.
results
A total of six hundred and thirty-four prostate tissues were 
submitted for histology during the study period. 63.6% (403) 
of these specimens were prostatectomies, while the remaining 
were core biopsies [Figure 1]. Almost all the cases (436) 
analyzed occurred in men 40 years and above and specifically 
in the 7th and 8th decades [Table 1]. The spectrum of prostate 
diseases seen includes nodular hyperplasia, adenocarcinoma, 
prostate intraepithelial neoplasia (PIN), and prostatitis.
Nodular hyperplasia (with or without chronic prostatic 
inflammation) was the most prevalent prostatic disease seen 
over the study period accounting for 542 cases (85.5%), 
with only 41 cases of these being nodular hyperplasia with 
chronic prostatic inflammation. 37.8% (205 cases) of the 
nodular hyperplasia were seen in the 7th decade, whereas 
29.9% (162 cases) occurred a decade later [Table 1].
The second in frequency to the nodular hyperplasia as observed 
in this study was prostatic adenocarcinoma accounting 
for 89 (14%) of the total cases. The majority of these cases, 
35 (39.3%), were seen in the 8th decade, while 32 (36%) other 
cases occurred a decade earlier (7th) [Table 1].
Two cases of high-grade PIN (HGPIN) and a case of chronic 
prostatic inflammation were also seen [Table 1].
dIscussIon
Prostatectomies (63.6%) constituted the most predominant type 
of prostate specimens submitted for histology during the study 
period, with the other being core biopsies (36.4%). A similar study 
in Kano[10] showed that all their prostate specimens were either core 
biopsies or prostatectomies too, but without stating the frequency 
of each type like our study. In a study of 529 cases reviewed by 
Obiorah and Nwosu,[9] 56.9% were core biopsies, while 43.1% 
were prostatectomy specimens. These findings contrast our study 
probably because while Obiorah and Nwosu looked at prostate 
cancers only, this study encompasses all prostatic diseases ranging 
from inflammatory to benign to malignant in which treatment for 
some of these diseases is usually prostatectomy. Studies by Bhatta 
and Hirachan, Mosli et al., and Satyasri et al.[4,11,12] showed core 
biopsies and TURP predominating over prostatectomy in contrast 
to our findings. This finding may not be unconnected to the lack of 
expertise or equipment to perform this procedure (TURP) during 
the study period in our center.
The majority of prostate diseases in this study were 
benign (85.7%), with HGPIN accounting for just 0.3% while 
14.0% were malignant. A study by Bhatta and Hirachan,[4] 
also showed benign prostate lesions (89.58%) predominating 
over carcinoma (8.34%) and HGPIN (2.08%), while Yadav 
et al. recorded 93% and 7% for benign and malignant lesions, 
respectively.
The frequency of all prostate diseases in this study rose steeply 
from the 6th decade, peaked at the seventh decade of life after 
which it declined gradually until the 9th decade of life [Table 1]. 
This finding is not different from many other studies within and 
outside Nigeria.[7,13] However, some reports from the Caucasian 
series show a steady progressive rise in the incidence with a 
peak at the 9th decade of life.[13]
Nodular hyperplasia of the prostate whether in its pure 
form or in combination with chronic prostatitis was the 
most frequent lesion of the prostate observed in this study. 
It accounted for 85.5% of the prostate biopsies reviewed. 
Similar studies in Benin City, Nigeria, reported 74.9%[13] while 
(80.3%)[14] and (85.0%)[7] were reported in Saudi Arabia and 
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Figure 1: Pie chart showing types of specimens in prostate diseases
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India respectively.  Nodular hyperplasia microscopically shows 
proliferation of epithelial and fibromuscular stromal cells in 
nodular configurations. Some of the glands are cystically 
dilated with papillary infoldings and contain thick secretions 
in their lumen called corpora amylacea. The glands are lined 
by a double layer of epithelium [Figure 2].
Prostatitis is inflammation of prostate glands. It can be acute, 
chronic, or granulomatous.[6] Acute prostatitis occurs when 
there are neutrophils within glands and stroma, intraductal 
cellular debris, and stromal edema. This type of prostatitis 
is uncommon in surgical specimens.[1] No case of acute 
prostatitis was reported in this study. Chronic prostatitis is 
however more common whether in its pure form or coexisting 
with nodular hyperplasia. In this study, nodular hyperplasia 
with coexisting chronic prostatic inflammation was seen in 
41 (6.5%) cases, whereas only one case (0.2%) of chronic 
prostatic inflammation without nodular hyperplasia was 
recorded. Chronic inflammation involves the prostate usually 
in periglandular distribution and contains an admixture of 
plasma cells, lymphocytes, and histiocytes.[1]
PIN is the most established precursor of carcinoma of 
the prostate.[4,5] Clinical studies suggest that PIN predates 
carcinoma by 10 years or more, with low‑grade PIN first 
appearing in men in their thirties. The findings of PIN indicate 
the need for repeated biopsy and follow-up because they are at 
risk for malignancy, especially in patients with elevated serum 
PSA concentration.[5]
Two cases (0.3%) of PIN, both of which were HGPIN, were 
seen in the 7th and 8th decades, respectively, in this study. 
Aligbe et al. in Benin City, Nigeria recorded two cases (0.2%) 
of HGPIN similar to our finding. A case of HGPIN (0.44%) 
was seen by Deshmukh et al.,[15] while a couple of studies 
in India also recorded two cases (1.3%) and (2.08%) each 
of PIN, all of which were HGPIN.[4,5] These findings of ours 
and others mentioned above showed that HGPIN is relatively 
more frequent than its low-grade counterpart. It may also be 
attributable to lack of consensus as to the histological criteria 
required to diagnose low-grade PIN
Prostate cancers accounted for 14.0% of all prostate 
diseases seen in this study, of which 13.4% were acinar 
adenocarcinoma [Figure 3], while only 0.6% were ductal 
adenocarcinoma (carcinoma of large duct type). This study 
showed a steep increase in the frequency of prostate cancer 
from the 7th decade with a peak in the 8th decade of life. This is 
similar to several previous studies in Port Harcourt, Nigeria,[9] 
Table 1: Age distribution, histopathologic pattern, and frequencies of various prostatic diseases
Histopathologic type Age (years) Frequency, 
n (%)<40 40‑49 50‑59 60‑69 70‑79 80‑89 90‑99 100‑109
Nodular hyperplasia 1 11 80 187 151 62 7 2 501 (79.0)
Nodular hyperplasia+chronic prostatic inflammation 1 6 18 11 4 1 41 (6.5)
Chronic prostatic inflammation 1 1 (0.2)
Prostatic intraepithelial neoplasm 1 1 2 (0.3)
Malignant (adenocarcinoma)
Acinar 1 11 29 35 8 1 85 (13.4)
Ductal 3 1 4 (0.6)
Total 1 13 97 238 198 76 9 2 634 (100)
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Figure 2: Photomicrograph showing cystically dilated glands with some 
papillary infoldings in nodular hyperplasia of the prostate (H and E, ×40)
Figure 3: Photomicrograph showing small glands lined by a single layer 
of cells with moderate intervening stroma equivalent to (Gleason 3 + 3) 
in acinar type adenocarcinoma of the prostate (H and E, ×40)
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and India.[15,16] However, Aligbe, Abubakar, and Anunobi et al., 
all in Nigeria, reported peak age in the 7th decade. Few other 
studies outside of Nigeria such as Yadav et al. and Paul et al. 
also reported peak age in the 7th decade. These mixed findings 
suggest that prostate cancers were most prevalent between 
these two decades (7th and 8th) worldwide, especially in Africa, 
Asia, and the Middle East.
conclusIon
This study has shown that prostate diseases generally are 
mostly prevalent in the 6th through 9th decades of life, with 
nodular hyperplasia being the most common lesion of the 
prostate.
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